莫沙必利与雷贝拉唑联合治疗42例反流性食管炎的效果

目的探讨莫沙必利与雷贝拉唑联合治疗反流性食管炎的效果。方法2008年2月～2013年2月期间前来我院治疗反流性食管炎的84例患者，随机分成两组，治疗组给予莫沙必利联合雷贝拉唑，对照组给予法莫替丁联合莫沙必利。对两组患者的临床疗效以及胃镜下疗效进行对比。结果治疗组无论是临床疗效，还是胃镜下疗效均显著优于对照组（P〈0．05）。结论对于反流性食管炎患者给予莫沙必利同雷贝拉唑联合的治疗方法，不但治疗效果十分显著，且服用方法非常方便，值得推广至相应临床。

42 cases of reflux esophagitis effect of mosapride combination therapy with rabeprazole

Objective Research and discussion mosapride combination therapy with rabeprazole reflux esophagitis effect experience. Methods Selected 84 cases in February 2008 to February 2013 came to our hospital for treatment of reflux esophagitis patients, then evenly divided into two groups, the treatment group were given rabeprazole Mosapride joint, control group was given method famotidine mosapride. Under the efficacy of endoscopic and clinical efficacy of the two groups of patients were compared. Results Both the clinical efficacy and endoscopic efficacy of the treatment group, were significantly better than the control group（P 〈 0.05）. Conclusion For patients with reflux esophagitis treatment given mosapride combined with rabeprazole, not only the treatment effect is very significant, and very convenient way of taking, worthy of promotion to the appropriate clinical use.